Veristat Group recapitalized by WindRose Health Investors

Apr. 2021

Client: Veristat Group is a scientifically minded global clinical research organization that empowers biotech and pharmaceutical sponsors to solve unique and complex challenges associated with accelerating innovative therapies from clinical development to regulatory approval and post-approval

Role: Edgemont Partners acted as exclusive financial advisor to Veristat Group in its recapitalization by WindRose Health Investors

Location: Southborough, MA

Sector: Pharmaceutical Services

Lead Banker: David Blume

View Press Release

recapitalized by

Get In Touch